dc.contributor.author | Lo, Vincent | eng |
dc.contributor.author | Noviasky, John | eng |
dc.contributor.author | Nashelsky, Joan | eng |
dc.date.issued | 2006 | eng |
dc.description.abstract | There is no evidence that anticoagulation with warfarin, initiated after a non- cardioembolic ischemic stroke, significantly reduces stroke recurrence. Furthermore, anticoagulation significantly increases the risk of fatal and nonfatal hemorrhagic stroke and extracranial hemorrhage in these patients. However, warfarin clearly is indicated for patients who have embolic strokes caused by underlying conditions such as atrial fibrillation or myxoma. (Strength of recommendation: A) | eng |
dc.identifier.uri | http://hdl.handle.net/10355/3969 | eng |
dc.language | English | eng |
dc.publisher | Family Physicians Inquiries Network | eng |
dc.relation.ispartofcollection | Clinical Inquiries, 2006 (MU) | eng |
dc.relation.ispartofcommunity | University of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network | eng |
dc.relation.ispartofseries | American family physician, 73, no. 11 (June 2006) | eng |
dc.rights | OpenAccess. | eng |
dc.rights.license | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License. | eng |
dc.subject | intracranial hemorrhage | eng |
dc.subject | cardioembolic stroke | eng |
dc.subject | antiplatelet agents | eng |
dc.subject.lcsh | Warfarin | eng |
dc.subject.lcsh | Cardiovascular system -- Diseases | eng |
dc.subject.lcsh | Intracranial aneurysms | eng |
dc.subject.lcsh | Subarachnoid hemorrhage | eng |
dc.subject.lcsh | Cerebral ischemia | eng |
dc.subject.lcsh | Anticoagulants | eng |
dc.subject.lcsh | Atrial fibrillation | eng |
dc.title | Warfarin for Prevention of Ischemic Stroke Recurrence? | eng |
dc.type | Article | eng |